Daily news email for June 20, 2012 | Click here for updated news
BioSpace - Breaking News
QUMAS Announces Appointment of as Chairman
CytoSorbents, Inc. Announces Departure of CFO
AspenBio Pharma, Inc. Announces Pricing of Public Offering of 6,100,000 Shares of Common Stock
Cytokinetics, Inc. Announces Proposed Public Offerings of Common Stock and Warrants and Series B Convertible Preferred Stock and Warrants
Cytokinetics, Inc. Receives Notice of Minimum Bid Price Non-Compliance
|
Biotech News - Business Wire
New Coalition Brings Life Science Education, Workforce Training and Entrepreneurship to the National Stage
Biotechnology Institute Leads Effort to Bring Life Science Education, Workforce Training and Entrepreneurship to the National Stage
Dr. Margaret Foti Receives 2012 Biotech Humanitarian Award
VG Energy to Launch First Commercial Product, LipidMax for Palm and Algae Oil Production
Retinalyze, LLC Signs Licensing Agreement for Vision Plan Reimbursement
|
Biotech News - PR Newswire
PRA Experts to Present at DIA Annual Conference
Healthpoint Biotherapeutics To Create State-of-the-Art Cell Sciences Manufacturing Facility
Thomson Reuters registriert Anstieg neuer Forschungsaktivitäten bei vernachlässigten" Tropenkrankheiten
Thomson Reuters constate une augmentation du nombre de recherches portant sur les maladies tropicales négligées
University of North Texas Health Science Center Advances Forensic Research by Investing in Semiconductor DNA Sequencing Technology
|
Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)
NIH Translational Center Should Raise All Boats, BIO Says
Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update
Biotechnology to be 21st-century industry: Life Tech CEO
|
Burrill Report
The July 2012 Issue of The Burrill Report
Mapping the Single Cell World
A Gentleman's D for Mitt
Startups raise $786 million in June's First Half
A Drug by Any Other Name
|
CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend
New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising
Technology companies adapt interactive video concepts for clinical trial informed consent
CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases
New $1b NIH center will tackle early-stage drug development to ease industry risk of failure
|
